United States Biotechnology & Medical Research

Actuate Therapeutics Inc (ACTU)

Track

Track

Actuate Therapeutics Inc has seen no insider trading activity within the last three months. The most recent recorded transaction occurred on January 5, 2026, involving a sale of shares by Todd S. Thomson. Prior historical data reflects various buying and selling patterns by affiliates and key stakeholders throughout 2024 and 2025.
Ticker: ACTU Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Actuate Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.3
THOMSON TODD S Non-Executive Director Large shareholder
Transaction date
Sale
Price
265.44
Quantity 8,411 -4.3%
Value US$4,542,047
2.7
Fletcher Aaron G.L. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
194.20
Quantity 19,718 -42.8%
Value US$4,107,647
2.4
Bios Equity COF, LP Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.00
Quantity 71,428 +57.1%
Value US$499,996
2.9
Kreis Leslie W. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.00
Quantity 71,428 +57.1%
Value US$499,996
3.3
THOMSON TODD S Non-Executive Director
Transaction date
Sale
Price
8.00
Quantity 18,750 -1.6%
Value US$150,000
2.7
Fletcher Aaron G.L. Non-Executive Director Large shareholder
Transaction date
Sale
Price
9.00
Quantity 2,324 -1.7%
Value US$20,916
2.7
Fletcher Aaron G.L. Non-Executive Director Large shareholder
Transaction date
Sale
Price
9.00
Quantity 17,361 -1.7%
Value US$156,249
2.7
Fletcher Aaron G.L. Non-Executive Director Large shareholder
Transaction date
Sale
Price
9.00
Quantity 5,314 -1.7%
Value US$47,826
2.7
Fletcher Aaron G.L. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.00
Quantity 125,000 +inf%
Value US$1,000,000
2.7
Fletcher Aaron G.L. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.00
Quantity 375,000 +42.4%
Value US$3,000,000
2.4
Bios Equity COF, LP Non-Executive Director Large shareholder
Transaction date
Sale
Price
9.00
Quantity 2,324 -1.7%
Value US$20,916
2.4
Bios Equity COF, LP Non-Executive Director Large shareholder
Transaction date
Sale
Price
9.00
Quantity 17,361 -1.7%
Value US$156,249
2.4
Bios Equity COF, LP Non-Executive Director Large shareholder
Transaction date
Sale
Price
9.00
Quantity 5,314 -1.7%
Value US$47,826
2.4
Bios Equity COF, LP Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.00
Quantity 125,000 +inf%
Value US$1,000,000
2.4
Bios Equity COF, LP Non-Executive Director Large shareholder
Transaction date
Purchase
Price
8.00
Quantity 375,000 +42.4%
Value US$3,000,000
2.9
Kreis Leslie W. Large shareholder
Transaction date
Sale
Price
9.00
Quantity 2,324 -1.7%
Value US$20,916
2.9
Kreis Leslie W. Large shareholder
Transaction date
Sale
Price
9.00
Quantity 17,361 -1.7%
Value US$156,249
2.9
Kreis Leslie W. Large shareholder
Transaction date
Sale
Price
9.00
Quantity 5,314 -1.7%
Value US$47,826
2.9
Kreis Leslie W. Large shareholder
Transaction date
Purchase
Price
8.00
Quantity 125,000 +inf%
Value US$1,000,000
2.9
Kreis Leslie W. Large shareholder
Transaction date
Purchase
Price
8.00
Quantity 375,000 +42.4%
Value US$3,000,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-07 2026-01-05 S Sale
3.3
THOMSON TODD S
Non-Executive Director Large shareholder
8,411 -4.3%
265.44
US$4,542,047 		8,411 -4.3% 265.44 US$4,542,047
2025-12-11 2025-12-11 PrS Proposed sale
Kairos Venture Partners II, L.P.

Affiliate
81,000
403.23
US$3,156,843 		81,000 403.23 US$3,156,843
2025-06-30 2025-06-27 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
19,718 -42.8%
194.20
US$4,107,647 		19,718 -42.8% 194.20 US$4,107,647
2025-06-30 2025-06-27 B Purchase
2.4
Bios Equity COF, LP
Non-Executive Director Large shareholder
71,428 +57.1%
7.00
US$499,996 		71,428 +57.1% 7.00 US$499,996
2025-06-30 2025-06-27 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director Large shareholder
71,428 +57.1%
7.00
US$499,996 		71,428 +57.1% 7.00 US$499,996
2024-08-16 2024-08-14 S Sale
3.3
THOMSON TODD S
Non-Executive Director
18,750 -1.6%
8.00
US$150,000 		18,750 -1.6% 8.00 US$150,000
2024-08-14 2024-08-14 S Sale
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
2,324 -1.7%
9.00
US$20,916 		2,324 -1.7% 9.00 US$20,916
2024-08-14 2024-08-14 S Sale
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
17,361 -1.7%
9.00
US$156,249 		17,361 -1.7% 9.00 US$156,249
2024-08-14 2024-08-14 S Sale
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
5,314 -1.7%
9.00
US$47,826 		5,314 -1.7% 9.00 US$47,826
2024-08-14 2024-08-14 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
125,000 +inf%
8.00
US$1,000,000 		125,000 +inf% 8.00 US$1,000,000
2024-08-14 2024-08-14 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
375,000 +42.4%
8.00
US$3,000,000 		375,000 +42.4% 8.00 US$3,000,000
2024-08-14 2024-08-14 S Sale
2.4
Bios Equity COF, LP
Non-Executive Director Large shareholder
2,324 -1.7%
9.00
US$20,916 		2,324 -1.7% 9.00 US$20,916
2024-08-14 2024-08-14 S Sale
2.4
Bios Equity COF, LP
Non-Executive Director Large shareholder
17,361 -1.7%
9.00
US$156,249 		17,361 -1.7% 9.00 US$156,249
2024-08-14 2024-08-14 S Sale
2.4
Bios Equity COF, LP
Non-Executive Director Large shareholder
5,314 -1.7%
9.00
US$47,826 		5,314 -1.7% 9.00 US$47,826
2024-08-14 2024-08-14 B Purchase
2.4
Bios Equity COF, LP
Non-Executive Director Large shareholder
125,000 +inf%
8.00
US$1,000,000 		125,000 +inf% 8.00 US$1,000,000
2024-08-14 2024-08-14 B Purchase
2.4
Bios Equity COF, LP
Non-Executive Director Large shareholder
375,000 +42.4%
8.00
US$3,000,000 		375,000 +42.4% 8.00 US$3,000,000
2024-08-14 2024-08-14 S Sale
2.9
Kreis Leslie W.
Large shareholder
2,324 -1.7%
9.00
US$20,916 		2,324 -1.7% 9.00 US$20,916
2024-08-14 2024-08-14 S Sale
2.9
Kreis Leslie W.
Large shareholder
17,361 -1.7%
9.00
US$156,249 		17,361 -1.7% 9.00 US$156,249
2024-08-14 2024-08-14 S Sale
2.9
Kreis Leslie W.
Large shareholder
5,314 -1.7%
9.00
US$47,826 		5,314 -1.7% 9.00 US$47,826
2024-08-14 2024-08-14 B Purchase
2.9
Kreis Leslie W.
Large shareholder
125,000 +inf%
8.00
US$1,000,000 		125,000 +inf% 8.00 US$1,000,000
2024-08-14 2024-08-14 B Purchase
2.9
Kreis Leslie W.
Large shareholder
375,000 +42.4%
8.00
US$3,000,000 		375,000 +42.4% 8.00 US$3,000,000
Explore more

More insider trading research around Actuate Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America